A systematic review and meta-analysis of 25 randomized controlled trials yielded no significant association between statin therapy and cognitive impairment.
Risks associated with noncardiac surgery are highest in the first 6 months after coronary stent implantation, and a new study suggests that delaying noncardiac surgery for at least 6 months may yield improved outcomes in patients after stenting.
Sanofi and Regeneron Pharmaceuticals Inc. announced that the phase 3 ODYSSEY CHOICE I and CHOICE II trials had each met their primary efficacy endpoints for monthly treatment with alirocumab in patients with hypercholesterolemia.
Data from the ATRIA-CVRN study suggest an association between digoxin and increased risk for death and hospitalization in patients with atrial fibrillation.
Данный сайт и вся информация на нём предназначена для медицинских работников.
Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.